{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T07:20:35Z","timestamp":1785396035969,"version":"3.56.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002848","name":"Comisi\u00c3\u00b3n Nacional de Investigaci\u00c3\u00b3n Cient\u00c3\u00adfica y Tecnol\u00c3\u00b3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.bcp.2020.113941","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T10:46:08Z","timestamp":1585565168000},"page":"113941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Src-family kinase inhibitors block early steps of caveolin-1-enhanced lung metastasis by melanoma cells"],"prefix":"10.1016","volume":"177","author":[{"given":"Rina","family":"Ortiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"D\u00edaz-Valdivia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layla","family":"Sim\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Lobos-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sim\u00f3n","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisette","family":"Leyton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew F.G.","family":"Quest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bcp.2020.113941_b0005","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1096\/fj.14-252320","article-title":"Regulation of intracellular signaling and function by caveolin","volume":"28","author":"Fridolfsson","year":"2014","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.bcp.2020.113941_b0010","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.molmed.2016.08.007","article-title":"Caveolin-1 function in liver physiology and disease","volume":"22","author":"Fernandez-Rojo","year":"2016","journal-title":"Trends Mol. Med."},{"issue":"129","key":"10.1016\/j.bcp.2020.113941_b0015","first-page":"1","article-title":"The role of caveolin 1 in HIV infection and pathogenesis","volume":"9","author":"Mergia","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.bcp.2020.113941_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2019.104315","article-title":"Caveolin-1 as a critical component in the pathogenesis of lung fibrosis of different etiology: Evidences and mechanisms","volume":"111","author":"Kulshrestha","year":"2019","journal-title":"Exp. Mol. Pathol."},{"issue":"5","key":"10.1016\/j.bcp.2020.113941_b0025","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1073\/pnas.92.5.1381","article-title":"Reduction of caveolin and caveolae in oncogenically transformed cells","volume":"92","author":"Koleske","year":"1995","journal-title":"PNAS"},{"issue":"20","key":"10.1016\/j.bcp.2020.113941_b0030","first-page":"5870","article-title":"Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity","volume":"60","author":"Bender","year":"2000","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bcp.2020.113941_b0035","doi-asserted-by":"crossref","first-page":"C494","DOI":"10.1152\/ajpcell.00458.2004","article-title":"Caveolin-1 in oncogenic transformation, cancer, and metastasis","volume":"288","author":"Williams","year":"2005","journal-title":"Am. J. Physiol.-Cell Physiol."},{"issue":"4","key":"10.1016\/j.bcp.2020.113941_b0040","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1582-4934.2008.00331.x","article-title":"Caveolin-1: An ambiguous partner in cell signalling and cancer","volume":"12","author":"Quest","year":"2008","journal-title":"J. Cell Mol. Med."},{"issue":"7","key":"10.1016\/j.bcp.2020.113941_b0045","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/ijc.24451","article-title":"Caveolin-1 tumor-promoting role in human melanoma","volume":"125","author":"Felicetti","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.bcp.2020.113941_b0050","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/pcmr.12085","article-title":"E-cadherin determines Caveolin-1 tumor suppression or metastasis enhancing function in melanoma cells","volume":"26","author":"Lobos-Gonz\u00e1lez","year":"2013","journal-title":"Pigment Cell and Melanoma Research"},{"issue":"2","key":"10.1016\/j.bcp.2020.113941_b0055","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ceb.2011.12.004","article-title":"Directed cell invasion and migration during metastasis","volume":"24","author":"Bravo-Cordero","year":"2012","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bcp.2020.113941_b0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.copbio.2016.02.007","article-title":"Impact of the physical microenvironment on tumor progression and metastasis","volume":"40","author":"Spill","year":"2016","journal-title":"Curr. Opin. Biotechnol."},{"issue":"8","key":"10.1016\/j.bcp.2020.113941_b0065","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1091\/mbc.e08-10-1076","article-title":"ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells","volume":"20","author":"Drake","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bcp.2020.113941_b0070","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10585-007-9098-2","article-title":"Stepping out of the flow: Capillary extravasation in cancer metastasis","volume":"25","author":"Miles","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"issue":"15","key":"10.1016\/j.bcp.2020.113941_b0075","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1096\/fj.04-2516rev","article-title":"A role for caveolae in cell migration","volume":"18","author":"Navarro","year":"2004","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.bcp.2020.113941_b0080","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1023\/A:1006110326366","article-title":"Metastasis-related genes in prostate cancer: The role of caveolin-1","volume":"17","author":"Thompson","year":"1998","journal-title":"Cancer Metastasis Rev."},{"issue":"8","key":"10.1016\/j.bcp.2020.113941_b0085","first-page":"1873","article-title":"Elevated expression of caveolin is associated with prostate and breast cancer","volume":"4","author":"Yang","year":"1998","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bcp.2020.113941_b0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3409\/fb64_3.145","article-title":"Expression of caveolin-1 in human cutaneous and uveal melanoma cells","volume":"64","author":"Be\u0142kot","year":"2016","journal-title":"Folia Biologica (Poland)"},{"issue":"10","key":"10.1016\/j.bcp.2020.113941_b0095","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/sj.bjc.6601359","article-title":"Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma","volume":"89","author":"Campbell","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.bcp.2020.113941_b0100","first-page":"601","article-title":"The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma","volume":"18","author":"Ando","year":"2007","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2020.113941_b0105","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/sj.bjc.6604243","article-title":"Combined expression of caveolin-1 and an activated AKT\/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma","volume":"98","author":"Campbell","year":"2008","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2020.113941_b0110","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s12032-011-9900-5","article-title":"Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer","volume":"29","author":"Tang","year":"2012","journal-title":"Med. Oncol."},{"issue":"10","key":"10.1016\/j.bcp.2020.113941_b0115","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1074\/jbc.273.10.5419","article-title":"Caveolins, a family of scaffolding proteins for organizing \u201cpreassembled signaling complexes\u201d at the plasma membrane","volume":"273","author":"Okamoto","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.bcp.2020.113941_b0120","doi-asserted-by":"crossref","first-page":"25574","DOI":"10.1074\/jbc.M310807200","article-title":"Cell type-specific occurrence of caveolin-1\u03b1 and -1\u03b2 in the lung caused by expression of distinct mRNAs","volume":"279","author":"Kogo","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2020.113941_b0125","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1242\/jcs.01402","article-title":"Dynamics and interaction of caveolin-1 isoforms with BMP-receptors","volume":"118","author":"Nohe","year":"2005","journal-title":"J. Cell Sci."},{"issue":"6","key":"10.1016\/j.bcp.2020.113941_b0130","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.2353\/ajpath.2006.060562","article-title":"Caveolin-1\u03b1 and -1\u03b2 perform nonredundant roles in early vertebrate development","volume":"169","author":"Fang","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.bcp.2020.113941_b0135","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1074\/jbc.271.7.3863","article-title":"Phosphorylation of caveolin by Src tyrosine kinases: The \u03b1-isoform of caveolin is selectively phosphorylated by v-Src in vivo","volume":"271","author":"Li","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2020.113941_b0140","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0898-6568(02)00090-6","article-title":"C-Abl is required for oxidative stress-induced phosphorylation of caveolin-1 on tyrosine 14","volume":"15","author":"Sanguinetti","year":"2003","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.bcp.2020.113941_b0145","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/bj20030336","article-title":"Fyn is required for oxidative- and hyperosmotic-stress-induced tyrosine phosphorylation of caveolin-1","volume":"376","author":"Sanguinetti","year":"2003","journal-title":"Biochem. J"},{"issue":"6","key":"10.1016\/j.bcp.2020.113941_b0150","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1083\/jcb.200709019","article-title":"Concerted regulation of focal adhesion dynamics by galectin-3 and tyrosine-phosphorylated caveolin-1","volume":"180","author":"Goetz","year":"2008","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.bcp.2020.113941_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033085","article-title":"Caveolin-1-enhanced motility and focal adhesion turnover require tyrosine-14 but not accumulation to the rear in metastatic cancer cells","volume":"7","author":"Urra","year":"2012","journal-title":"PLoS ONE"},{"issue":"26","key":"10.1016\/j.bcp.2020.113941_b0160","doi-asserted-by":"crossref","first-page":"40571","DOI":"10.18632\/oncotarget.9738","article-title":"Extracellular matrix-specific Caveolin-1 phosphorylation on tyrosine 14 is linked to augmented melanoma metastasis but not tumorigenesis","volume":"7","author":"Ortiz","year":"2016","journal-title":"Oncotarget"},{"issue":"20","key":"10.1016\/j.bcp.2020.113941_b0165","doi-asserted-by":"crossref","first-page":"8210","DOI":"10.1158\/0008-5472.CAN-08-0343","article-title":"Phosphorylated caveolin-1 regulates Rho\/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion","volume":"68","author":"Joshi","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2020.113941_b0170","doi-asserted-by":"crossref","unstructured":"N.I. D\u00edaz-Valdivia et al. \u2018The non-receptor tyrosine phosphatase type 14 blocks caveolin-1-enhanced cancer cell metastasis\u2019, Oncogene 2020 Springer US 10.1038\/s41388-020-1242-3.","DOI":"10.1038\/s41388-020-1242-3"},{"key":"10.1016\/j.bcp.2020.113941_b0175","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ctrv.2010.02.015","article-title":"Dasatinib: a potent SRC inhibitor in clinical development for the treatment of solid tumors","volume":"36","author":"Araujo","year":"2010","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2020.113941_b0180","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/bj20021535","article-title":"The specificities of protein kinase inhibitors: an update","volume":"371","author":"Bain","year":"2003","journal-title":"Biochem. J"},{"issue":"5","key":"10.1016\/j.bcp.2020.113941_b0185","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1074\/jbc.M409040200","article-title":"Loss of caveolin-1 polarity impedes endothelial cell polarization and directional movement","volume":"280","author":"Beardsley","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2020.113941_b0190","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.clim.2008.02.006","article-title":"The Src\/ABL kinase inhibitor dasatinib (BMS-354825) inhibits function of normal human T-lymphocytes in vitro","volume":"127","author":"Blake","year":"2008","journal-title":"Clin. Immunol."},{"issue":"11","key":"10.1016\/j.bcp.2020.113941_b0195","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1158\/1541-7786.MCR-08-0169","article-title":"Inhibition of Src family kinases with dasatinib blocks migration and invasion of human melanoma cells","volume":"6","author":"Buettner","year":"2008","journal-title":"Mol. Cancer Res."},{"issue":"11","key":"10.1016\/j.bcp.2020.113941_b0200","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.1074\/jbc.C100661200","article-title":"A phosphotyrosine-dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14. Recruitment of C-terminal Src kinase","volume":"277","author":"Cao","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"65","key":"10.1016\/j.bcp.2020.113941_b0205","article-title":"Differential expression of Caveolin-1 in hepatocellular carcinoma: Correlation with differentiation state, motility and invasion","volume":"9","author":"Cokakli","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2020.113941_b0210","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.2147\/IJN.S165565","article-title":"(2018) \u2018Biomimetic quantum dot-labeled B16F10 murine melanoma cells as a tool to monitor early steps of lung metastasis by in vivo imaging\u2019","volume":"13","author":"D\u00edaz-Garc\u00eda","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"67","key":"10.1016\/j.bcp.2020.113941_b0215","doi-asserted-by":"crossref","first-page":"111943","DOI":"10.18632\/oncotarget.22955","article-title":"Anti-neoplastic drugs increase caveolin-1-dependent migration, invasion and metastasis of cancer cells","volume":"8","author":"D\u00edaz-Valdivia","year":"2017","journal-title":"Oncotarget"},{"issue":"Pt 11","key":"10.1016\/j.bcp.2020.113941_b0220","first-page":"2401","article-title":"Rab5 is required in metastatic cancer cells for Caveolin-1-enhanced Rac1 activation, migration and invasion","volume":"127","author":"D\u00edaz","year":"2014","journal-title":"J. Cell Sci."},{"issue":"4","key":"10.1016\/j.bcp.2020.113941_b0225","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.clgc.2019.02.010","article-title":"Randomized Phase II Trial of Abiraterone Alone or With Dasatinib in Men With Metastatic Castration-resistant Prostate Cancer (mCRPC)","volume":"17","author":"Dorff","year":"2019","journal-title":"Clinical Genitourinary Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2020.113941_b0230","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2174\/156652413804810745","article-title":"The Caveolin-1 Connection to Cell Death and Survival","volume":"13","author":"Quest","year":"2013","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.bcp.2020.113941_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-13-209","article-title":"Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K\/Akt enhanced \u03b2-catenin\/Tcf-Lef dependent transcription","volume":"13","author":"Fern\u00e1ndez","year":"2014","journal-title":"Molecular Cancer"},{"issue":"7","key":"10.1016\/j.bcp.2020.113941_b0240","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1164\/rccm.201807-1292OC","article-title":"YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib","volume":"200","author":"Garmendia","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"34","key":"10.1016\/j.bcp.2020.113941_b0245","doi-asserted-by":"crossref","first-page":"20163","DOI":"10.1016\/S0021-9258(19)47038-5","article-title":"Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus","volume":"264","author":"Glenney","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bcp.2020.113941_b0250","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1002\/art.11178","article-title":"Enhanced degradation of proteins of the basal lamina and stroma by matrix metalloproteinases from the salivary glands of Sj\u00f6gren\u2019s syndrome patients: Correlation with reduced structural integrity of acini and ducts","volume":"48","author":"Goicovich","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.bcp.2020.113941_b0255","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2217\/nnm-2017-0390","article-title":"Gold nanoparticles as tracking devices to shed light on the role of caveolin-1 in early stages of melanoma metastasis","volume":"13","author":"Guerrero","year":"2018","journal-title":"Nanomedicine"},{"issue":"Suppl 2","key":"10.1016\/j.bcp.2020.113941_b0260","first-page":"1216","article-title":"In Vivo Vascular Casting","volume":"11","author":"Hainfeld","year":"2005","journal-title":"Microsc. Microanal."},{"issue":"2","key":"10.1016\/j.bcp.2020.113941_b0265","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1074\/jbc.271.2.695","article-title":"Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor: Study of Lck- and FynT-dependent T cell activation","volume":"271","author":"Hanke","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2020.113941_b0270","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/(SICI)1097-4644(19981215)71:4<524::AID-JCB7>3.0.CO;2-B","article-title":"Early effects of PP60(v-src) kinase activation on caveolae","volume":"71","author":"Ko","year":"1998","journal-title":"J. Cell. Biochem."},{"issue":"50","key":"10.1016\/j.bcp.2020.113941_b0275","doi-asserted-by":"crossref","first-page":"52132","DOI":"10.1074\/jbc.M409617200","article-title":"Src-mediated tyrosine phosphorylation of caveolin-1 induces its association with membrane type 1 matrix metalloproteinase","volume":"279","author":"Labrecque","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bcp.2020.113941_b0280","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1210\/mend.14.11.0553","article-title":"Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: Identification of a c-Src\/Cav-1\/Grb7 signaling cassette","volume":"14","author":"Lee","year":"2000","journal-title":"Mol. Endocrinol."},{"issue":"2","key":"10.1016\/j.bcp.2020.113941_b0285","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/CMR.0000000000000046","article-title":"Caveolin-1 is a risk factor for postsurgery metastasis in preclinical melanoma models","volume":"24","author":"Lobos-Gonzalez","year":"2014","journal-title":"Melanoma Res."},{"issue":"1","key":"10.1016\/j.bcp.2020.113941_b0290","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/excr.2001.5205","article-title":"Caveolin-1 and a 29-kDa caveolin-associated protein are phosphorylated on tyrosine in cells expressing a temperature-sensitive v-Abl kinase","volume":"266","author":"Mastick","year":"2001","journal-title":"Exp. Cell Res."},{"issue":"6","key":"10.1016\/j.bcp.2020.113941_b0295","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1083\/jcb.129.6.1523","article-title":"Insulin stimulates the tyrosine phosphorylation of caveolin","volume":"129","author":"Mastick","year":"1995","journal-title":"J. Cell Biol."},{"issue":"33","key":"10.1016\/j.bcp.2020.113941_b0300","doi-asserted-by":"crossref","first-page":"20706","DOI":"10.1074\/jbc.272.33.20706","article-title":"Insulin-stimulated tyrosine phosphorylation of caveolin is specific for the differentiated adipocyte phenotype in 3T3-L1 cells","volume":"272","author":"Mastick","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.bcp.2020.113941_b0305","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1091\/mbc.e17-05-0278","article-title":"The phospho-caveolin-1 scaffolding domain dampens force fluctuations in focal adhesions and promotes cancer cell migration","volume":"28","author":"Meng","year":"2017","journal-title":"Mol. Biol. Cell"},{"issue":"6","key":"10.1016\/j.bcp.2020.113941_b0310","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1158\/1535-7163.MCT-09-0075","article-title":"Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src\/Abl inhibitor, in freshly generated human pancreas cancer xenografts","volume":"8","author":"Messersmith","year":"2009","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.bcp.2020.113941_b0315","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00280-019-03805-6","article-title":"A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors","volume":"83","author":"Mettu","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2020.113941_b0320","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4155\/fmc.12.29","article-title":"An update on dual Src\/Abl inhibitors","volume":"4","author":"Musumeci","year":"2012","journal-title":"Future Med. Chem."},{"issue":"20","key":"10.1016\/j.bcp.2020.113941_b0325","doi-asserted-by":"crossref","first-page":"9185","DOI":"10.1158\/0008-5472.CAN-05-1731","article-title":"Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells","volume":"65","author":"Nam","year":"2005","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2020.113941_b0330","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4161\/cam.5.1.13702","article-title":"A model for phospho-caveolin-1-driven turnover of focal adhesions","volume":"5","author":"Nethe","year":"2011","journal-title":"Cell Adhes. Migration"},{"issue":"4","key":"10.1016\/j.bcp.2020.113941_b0335","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1091\/mbc.10.4.975","article-title":"Tyrosine-phosphorylated caveolin-1: Immunolocalization and molecular characterization","volume":"10","author":"Nomura","year":"1999","journal-title":"Mol. Biol. Cell"},{"issue":"8","key":"10.1016\/j.bcp.2020.113941_b0340","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1091\/mbc.e02-11-0761","article-title":"Differential caveolin-1 polarization in endothelial cells during migration in two and three dimensions","volume":"14","author":"Parat","year":"2003","journal-title":"Mol. Biol. Cell"},{"issue":"3","key":"10.1016\/j.bcp.2020.113941_b0345","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1044-579X(02)00023-8","article-title":"Laminin isoforms in tumor invasion, angiogenesis and metastasis","volume":"12","author":"Patarroyo","year":"2002","journal-title":"Semin. Cancer Biol."},{"issue":"9","key":"10.1016\/j.bcp.2020.113941_b0350","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/ncb1293","article-title":"Phospho-caveolin-1 mediates integrin-regulated membrane domain internalization","volume":"7","author":"del Pozo","year":"2005","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2020.113941_b0355","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/excr.2000.5069","article-title":"MMP-2 colocalizes with caveolae on the surface of endothelial cells","volume":"262","author":"Puyraimond","year":"2001","journal-title":"Exp. Cell Res."},{"issue":"11","key":"10.1016\/j.bcp.2020.113941_b0360","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1158\/1541-7786.MCR-10-0060","article-title":"Caveolin-1 modulates the ability of Ewing\u2019s sarcoma to metastasize","volume":"8","author":"S\u00e1inz-Jaspeado","year":"2010","journal-title":"Mol. Cancer Res."},{"issue":"6","key":"10.1016\/j.bcp.2020.113941_b0365","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cellsig.2012.02.011","article-title":"Src kinases catalytic activity regulates proliferation, migration and invasiveness of MDA-MB-231 breast cancer cells","volume":"24","author":"S\u00e1nchez-Bail\u00f3n","year":"2012","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.bcp.2020.113941_b0370","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1158\/0008-5472.CAN-05-2050","article-title":"Dasatinib (BMS-354825), a dual SRC\/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies","volume":"66","author":"Schittenhelm","year":"2006","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.bcp.2020.113941_b0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187173","article-title":"Evaluation of the efficacy of dasatinib, a Src\/Abl inhibitor, in colorectal cancer cell lines and explant mouse model","volume":"12","author":"Scott","year":"2017","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.bcp.2020.113941_b0380","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1158\/0008-5472.CAN-10-0730","article-title":"Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer","volume":"71","author":"Thomas","year":"2011","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bcp.2020.113941_b0385","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1091\/mbc.e09-09-0769","article-title":"Rab5 mediates caspase-8-promoted cell motility and metastasis","volume":"21","author":"Torres","year":"2010","journal-title":"Mol. Biol. Cell"},{"issue":"51","key":"10.1016\/j.bcp.2020.113941_b0390","doi-asserted-by":"crossref","first-page":"48269","DOI":"10.1074\/jbc.M105901200","article-title":"Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: Role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling","volume":"276","author":"Ushio-Fukai","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"22","key":"10.1016\/j.bcp.2020.113941_b0395","doi-asserted-by":"crossref","first-page":"8594","DOI":"10.1158\/0008-5472.CAN-09-2305","article-title":"Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells","volume":"69","author":"Yamaguchi","year":"2009","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bcp.2020.113941_b0400","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00690290","article-title":"Fibronectin and integrins in invasion and metastasis","volume":"14","author":"Akiyama","year":"1995","journal-title":"Cancer Metastasis Rev."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220301696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220301696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:14:49Z","timestamp":1757769289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295220301696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":80,"alternative-id":["S0006295220301696"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.113941","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Src-family kinase inhibitors block early steps of caveolin-1-enhanced lung metastasis by melanoma cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.113941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"113941"}}